RxDoctor Payments Data

Gary Rubin

Medical · Rockledge, FLNPI 1629167630

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,676,255 of the $2,113,639 with a category attached, or 79.3%. AbbVie accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $516,210, 2.7 times the $189,644 reported in 2021. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,113,639in general payments, 2019–2025

Across 2,383 payments — averaging $886.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2.1M
  • Galderma Laboratories, L.p.$168
  • Revance Therapeutics, Inc.$19

What the payments were for

  • Consulting fees$130,4366%
  • Speaking & faculty fees$1,676,25579%
  • Travel & lodging$257,47512%
  • Food & beverage$49,2762%
  • Education$1960%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)2,380$2,113,452
Galderma Laboratories, L.p.2$168
Revance Therapeutics, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,113,639 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Other medical in Rockledge

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →